Stock listing
OTC:AVCNF Avicanna Inc Stock
US listing (OTC) of Avicanna Inc · home listing TSX:AVCN
Follow Avicanna Inc into a list and get an email when it puts out news.
Share price · OTC:AVCNF
$0.075 USD +0.002 (+2.7%)
Close on Oct 27, 2026
- Day range
- $0.072 – $0.075 USDOct 27, 2026
- Volume
- 300 sharesOct 27, 2026
- Market cap
- $10.08M USDAt the close on Oct 27, 2026 · price × 134.4M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| TSX:AVCN · Home | $0.105 CAD | +0.005 (+5.0%) | 84,600 | $0.110 | $0.110 | $0.105 | $0.100 | Close on Oct 30, 2026 |
| OTC:AVCNF | $0.075 USD | +0.002 (+2.7%) | 300 | $0.072 | $0.075 | $0.072 | $0.073 | Close on Oct 27, 2026 |
| Frankfurt:0NN | €0.064 EUR | +0.004 (+6.7%) | — | €0.064 | €0.064 | €0.064 | €0.060 | Close on Oct 30, 2026 |
- Ticker
- OTC:AVCNF
- Asset type
- Stock
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest news release · Nov 2, 2026
Avicanna to Report Q3 2026 Results and Host Call on Nov. 12
Latest earnings call · Apr 7, 2026
Avicanna (TSX:AVCN) Q4 2025 Earnings Call
Replay and transcript
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 16 slides
Calls
Upcoming
Avicanna (TSX:AVCN) Q3 2026 Earnings Call
Thu, Nov 12, 2026 · 8:30 AM ET
Register
Replays
Avicanna (TSX:AVCN) Q4 2025 Earnings Call
Tue, Apr 07, 2026 · 8:00 AM ET
Watch TranscriptAvicanna (TSX:AVCN) Q4 2023 Earnings Call
Tue, Apr 02, 2024 · 8:30 AM ET
Watch TranscriptAvicanna (TSX:AVCN) Q3 2023 Earnings Call
Wed, Nov 15, 2023 · 9:30 AM ET
Watch Transcript
Latest news
Financings
Private placement of non-convertible debenture units
Oct 29, 2026 · US$1.43M
Closed: C$2M raised · C$1,000 a unit · Warrants at C$0.2 for 36 months · free to trade Mar 1, 2027
Use of proceeds: General working capital, G&A expenses, production and manufacturing expenditures, and research and clinical development
Private placement of units
Aug 19, 2026 · US$361,690
Closed: C$500,000 raised · C$0.15 a unit · ½ warrant at C$0.2
Buyers: Michael Porter
Use of proceeds: General working capital, G&A expenses, production and manufacturing expenditures, and research and clinical development
Decks
Investor Presentation (September 2026)
Investor deck · 16 slides · September 2026
Investor Presentation (June 2025)
Investor deck · 26 slides · June 2025
Investor Presentation (September 2023)
Investor deck · 26 slides · Sep 6, 2023
Investor Presentation (September 2022)
Investor deck · 10 slides · September 2022
Avicanna Inc on 6ix
- News releases
- 25 in the last 12 months · 106 in all · newest Nov 2, 2026 · oldest 2019
- Calls
- 3 calls with a replay · 3 with a transcript · latest Apr 7, 2026
- Decks
- 10 decks · latest September 2026
Where Avicanna Inc is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| TSX:AVCN · Home listing | TSX | Canada | CAD |
| OTC:AVCNF · This page | OTC | United States | USD |
| Cboe Canada:AVCN | Cboe Canada | Canada | CAD |
| LS Exchange:A2PN04 | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2PN04 | Lang & Schwarz | Germany | EUR |
| gettex:0NN | gettex | Germany | EUR |
| Frankfurt:0NN | Frankfurt | Germany | EUR |
| Munich:0NN | Munich | Germany | EUR |
| Stuttgart:0NN | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Avicanna Inc.